Connect with us

Hi, what are you looking for?

Digital Health

FDA Clears Dexcom Partner Web APIs

Dexcom (NSDQ:DXCM) announced today that it received FDA clearance for its Dexcom Partner Web application programming interfaces (APIs).

FDA Clears Dexcom Partner Web APIs

Dexcom (NSDQ:DXCM) announced today that it received FDA clearance for its Dexcom Partner Web application programming interfaces (APIs).

The San Diego-based company’s Dexcom Partner Web APIs enable invited third-party developers to integrate real-time continuous glucose monitoring (CGM) data into their digital health apps and devices.

Dexcom’s CGM data can be integrated into third-party apps and devices in a number of ways, allowing users to quickly see all their therapy data in one place and empower them to use the apps they find most beneficial for a more tailored experience.

The platform also enables in-the-moment diabetes management coaching and feedback.

“FDA clearance of our real-time APIs further solidifies Dexcom as the leader in interoperable CGM, giving Dexcom users even more choice in how they view and interact with their glucose data,” Dexcom chief technology officer Jake Leach said in a news release. “The new APIs will help seamlessly integrate the power of real-time Dexcom CGM data into some of the leading diabetes and digital health solutions.”

According to the release, a number of prominent diabetes and digital health companies have received invites to access the real-time APIs and are currently in the testing and development phase, including Garmin and Teladoc’s Livongo for Diabetes.

“Garmin welcomes the opportunity to bring Dexcom CGM data to runners, cyclists and everyday users who rely on the technology 24/7 to proactively manage their diabetes,” Garmin VP of fitness Joe Schrick said. “We are proud to be part of this integration that will allow users a secondary way to quickly and discreetly view estimated glucose levels and trends right from their smartwatch at any time.”

The post FDA clears Dexcom Partner Web APIs appeared first on Drug Delivery Business.

Seen on Drug Delivery Business: Article Link

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Latest News

BioTechnology

Baleon Capital, a one-year-old venture capital firm started by investment veteran Jon Kaiden, closed its first fund to invest in pre-Series A and Series...

Artificial Intelligence

The Asian digital health market is expected to be worth up to $100 billion by 2025.

Digital Health

Today, BoxGroup is announcing it has beefed up its war chest so that it can be that “first yes” to more companies with the...

CE Mark

Paragonix SherpaPak® CTS is the only commercially available FDA-cleared and CE-marked medical device for heart transportation and the only device to fit small pediatric...

You May Also Like

Artificial Intelligence

Digital Solutions In Healthcare Plug “digital healthcare solutions” into Google, and the results are clear: digital tools have taken the healthcare industry by storm....

Digital Health

The sky’s the limit for HealthTech PR and looking past traditional strategies to nontraditional avenues for engagement will allow agencies to stand out.

COVID-19

In Delray Beach, Florida, an emerging biopharma company, Cyrano Therapeutics, is planning a clinical trial using approved theophylline via a new intranasal pathway of...

Artificial Intelligence

Joe Mullings discusses the Microbot – Liberty robotic platform with Harel Gadot and how a new category of surgical robotics creates a new entry...